Zobrazeno 1 - 10
of 16
pro vyhledávání: '"David, Shimunov"'
Autor:
Joseph S. Lu, Austin C. Cao, David Shimunov, Lova Sun, John N. Lukens, Alexander Lin, Roger B. Cohen, Devraj Basu, Steven B. Cannady, Karthik Rajasekaran, Gregory S. Weinstein, Robert M. Brody
Publikováno v:
The Laryngoscope.
Autor:
Regev, Landau, Ana, Belkin, Sapir, Kon-Kfir, Nira, Koren-Morag, Avishay, Grupper, David, Shimunov, Ben-Ami, Sela, Ehud, Grossman, Gadi, Shlomai, Avshalom, Leibowitz
Publikováno v:
The Israel Medical Association journal : IMAJ. 24(11)
Most dyspneic patients in internal medicine departments have co-morbidities that interfere with the clinical diagnosis. The role of brain natriuretic peptide (BNP) levels is well-established in the acute setting but not in hospitalized patients.To ev
Autor:
David Shimunov, Rabie M. Shanti, Karthik Rajasekaran, Jason G. Newman, A. Chalian, Neil P. Sheth, Steven B. Cannady, Robert M. Brody, Leila J. Mady
Publikováno v:
Microsurgery. 42:117-124
Background Concerns regarding iatrogenic femur fracture may deter adoption of the anterolateral thigh osteomyocutaneous (ALTO) flap as an alternative reconstructive technique for large composite defects of the head and neck. We describe the evolution
Autor:
David Shimunov, Lova Sun, Robert M. Brody, Gregory S. Weinstein, Steven B. Cannady, Roger B. Cohen, Alexander Lin, Joshua Bauml, Jason G. Newman, John N. Lukens, Laurie A. Loevner, Aditi P. Singh, Karthik Rajasekaran, Charu Aggarwal, Ara A. Chalian, Christopher H. Rassekh, Erik X. Tan, Devraj Basu, Samuel Swisher-McClure, Bert W. O'Malley
Publikováno v:
Head & Neck. 43:3053-3061
BACKGROUND Patients with oropharyngeal cancer who undergo transoral robotic surgery (TORS) and have high-risk features generally receive adjuvant chemoradiotherapy or trimodality therapy (TMT). The notion that TMT leads to high toxicity is largely ba
Autor:
Bert W. O'Malley, Karthik Rajasekaran, Jason G. Newman, David Shimunov, Harman S. Parhar, Christopher H. Rassekh, Gregory S. Weinstein, Ara A. Chalian, Robert M. Brody, Steven B. Cannady
Publikováno v:
Otolaryngology–Head and Neck Surgery. 164:1222-1229
Despite epidemiologic evidence that second primaries occur infrequently in HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma, recent recommendations advocate for elective contralateral palatine tonsillectomy. We aimed to stu
Autor:
David Shimunov, Andrés M. Bur, Robert M. Brody, Elizabeth A. Nicolli, Urjeet Patel, Brianna Harris, William G. Albergotti
Publikováno v:
Head & Neck
Introduction The COVID‐19 pandemic has raised controversies regarding safe and effective care of head and neck cancer patients. It is unknown how much the pandemic has changed surgeon practice. Methods A questionnaire was distributed to head and ne
Autor:
Samuel Swisher-McClure, Christopher H. Rassekh, Karthik Rajasekaran, Devraj Basu, John N. Lukens, Harman S. Parhar, David Shimunov, Ryan M. Carey, Leila J. Mady, Gregory S. Weinstein, Roger B. Cohen, Steven B. Cannady, Justin R. Shinn, Ara A. Chalian, Jason G. Newman, Alexander Lin, Joshua Bauml, Robert M. Brody
Publikováno v:
Oral oncology. 123
Objectives Sex differences in surgically treated HPV-associated oropharyngeal squamous cell carcinoma are not defined due to the low number of affected women. We explored the oncologic outcomes of men and women with p16-positive oropharyngeal squamou
Autor:
Bert W. O'Malley, Ryan M. Carey, Justin R. Shinn, Karthik Rajasekaran, Leila J. Mady, Robert M. Brody, David Shimunov, Roger B. Cohen, Jason G. Newman, Alexander Lin, Joshua Bauml, Devraj Basu, Gregory S. Weinstein, John N. Lukens, Steven B. Cannady
Publikováno v:
The Laryngoscope. 131
OBJECTIVE To analyze the patterns, risk factors, and salvage outcomes for locoregional recurrences (LRR) after treatment with transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma (HPV+ OPSCC). STUDY DESIGN Retrosp
Autor:
Bert W. O'Malley, David Shimunov, Ara A. Chalian, Jason G. Newman, Devraj Basu, Gregory S. Weinstein, Steven B. Cannady, John N. Lukens, Charu Aggrawal, Karthik Rajasekaran, Harman S. Parhar, Samuel Swisher-McClure, Robert M. Brody, Roger B. Cohen, Alexander Lin, Joshua Bauml, Christopher H. Rassekh
Publikováno v:
HeadneckREFERENCES. 43(10)
Background Patients with human papillomavirus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC) continue to experience disappointing outcomes following chemoradiotherapy (CRT) and appreciable morbidity following historical surgical approac
Autor:
Robert M, Brody, David, Shimunov, Roger B, Cohen, Alexander, Lin, John N, Lukens, Lee, Hartner, Charu, Aggarwal, Umamaheswar, Duvvuri, Kathleen T, Montone, Jalal B, Jalaly, Virginia A, LiVolsi, Ryan M, Carey, Rabie M, Shanti, Karthik, Rajasekaran, Ara A, Chalian, Christopher H, Rassekh, Steven B, Cannady, Jason G, Newman, Bert W, O'Malley, Gregory S, Weinstein, Phyllis A, Gimotty, Devraj, Basu
Publikováno v:
Oral Oncol
OBJECTIVES: Increasing use of transoral robotic surgery (TORS) is likely to impact outcomes for HPV+ oropharyngeal squamous cell carcinomas (OPSCCs). We aimed to describe oncologic outcomes for a large HPV+ OPSCC cohort after TORS and develop a risk